Differences in mouse strain, STZ diabetes induction regimen and abatacept treatment protocol could account for some divergence between our present data and Fiorina et al. Fiorina et al waited for the mice to become hyperglycemic (2–4 days) to start CTLA4-Ig dosing. Here, CTLA4 is linked to diabetes mellitus.